Table 4.
Model 1 | Model 2 | |||
---|---|---|---|---|
β (95% CI) | P value | β (95% CI) | P value | |
Male | ||||
Global cognition | − 0.67 (− 0.86, − 0.48) | < 0.001 | − 0.68 (− 0.87, − 0.49) | < 0.001 |
Episodic memory | − 0.23 (− 0.33, − 0.14) | 0.012 | − 0.23 (− 0.32, − 0.14) | 0.014 |
Figure drawing | − 0.05 (− 0.08 to -0.02) | 0.067 | − 0.05 (− 0.08, − 0.03) | 0.064 |
TICS | − 0.39 (− 0.53, − 0.25) | 0.005 | − 0.44 (− 0.59, − 0.29) | 0.003 |
Female | ||||
Global cognition | − 0.10 (− 0.31, 0.08) | 0.571 | − 0.13 (− 0.33, 0.05) | 0.476 |
Episodic memory | − 0.01 (0.10, 0.08) | 0.903 | 0.00 (− 0.10, 0.09) | 0.963 |
Figure drawing | 0.01 (− 0.01 to 0.03) | 0.719 | 0.01 (− 0.02, 0,04) | 0.724 |
TICS | − 0.10 (− 0.24 to 0.04) | 0.465 | − 0.14 (− 0.31, − 0.03) | 0.298 |
Model 1: adjusted for baseline cognition, age, mean TC, education, marital status, residential area, and BMI.
Model 2: adjusted for Model 1 + smoking, drinking, depression, lipid-lowering therapy, hypertension, dyslipidaemia, diabetes mellitus, stroke, heart disease, and cancer.
Using multiple linear regression model, the adjusted unstandardized regression coefficients and P values were calculated with TC variability (mmol/L) used as a continuous measure.